|
1
|
Spencer BA, McBride RB, Hershman DL, Buono
D, Herr HW, Benson MC, Guptamohile S and Neugut AI: Adjuvant
intravesical bacillus calmette-guérin therapy and survival among
elderly patients with non-muscle-invasive bladder cancer. J Oncol
Pract. 9:92–98. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
2
|
Kawai K, Miyazaki J, Joraku A, Nishiyama H
and Akaza H: Bacillus Calmette-Guerin (BCG) immunotherapy for
bladder cancer: Current understanding and perspectives on
engineered BCG vaccine. Cancer Sci. 104:22–27. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
3
|
Saint F, Patard JJ, Irani J, Salomon L,
Hoznek A, Legrand P, Debois H, Abbou CC and Chopin DK: Leukocyturia
as a predictor of tolerance and efficacy of intravesical BCG
maintenance therapy for superficial bladder cancer. Urology.
57:617–622. 2001. View Article : Google Scholar : PubMed/NCBI
|
|
4
|
Ermert D, Niemiec MJ, Röhm M, Glenthøj A,
Borregaard N and Urban CF: Candida albicans escapes from mouse
neutrophils. J Leukoc Biol. 94:223–236. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Koga Y, Matsuzaki A, Suminoe A, Hattori H
and Hara T: Neutrophil-derived TNF-related apoptosis-inducing
ligand (TRAIL): A novel mechanism of antitumor effect by
neutrophils. Cancer Res. 64:1037–1043. 2004. View Article : Google Scholar : PubMed/NCBI
|
|
6
|
Antony VB, Sahn SA, Antony AC and Repine
JE: Bacillus Calmette-Guérin-stimulated neutrophils release
chemotaxins for monocytes in rabbit pleural spaces and in vitro. J
Clin Invest. 76:1514–1521. 1985. View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Moliva JI, Turner J and Torrelles JB:
Immune responses to bacillus Calmette-Guérin vaccination: Why do
they fail to protect against Mycobacterium tuberculosis? Front
Immunol. 8:4072017. View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Rosevear HM, Lightfoot AJ, O'Donnell MA
and Griffith TS: The role of neutrophils and TNF-related
apoptosis-inducing ligand (TRAIL) in bacillus Calmette-Guérin (BCG)
immunotherapy for urothelial carcinoma of the bladder. Cancer
Metastasis Rev. 28:345–353. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Hicks AM, Riedlinger G, Willingham MC,
Alexander-Miller MA, Von Kap-Herr C, Pettenati MJ, Sanders AM, Weir
HM, Du W, Kim J, et al: Transterable anticancer innate immunity in
spontaneous regression/complete resistance mice. Proc Natl Acad Sci
USA. 103:7753–7758. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Cui Z, Willingham MC, Hicks AM,
Alexandermiller MA, Howard TD, Hawkins GA, Miller MS, Weir HM, Du W
and DeLong CJ: Spontaneous regression of advanced cancer:
Identification of a unique genetically determined, age-dependent
trait in mice. Proc Natl Acad Sci USA. 100:6682–6687. 2003.
View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Souto JC, Vila L and Brú A:
Polymorphonuclear neutrophils and cancer: Intense and sustained
neutrophilia as a treatment against solid tumors. Med Res Rev.
31:311–363. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Suttmann H, Riemensberger J, Bentien G,
Schmaltz D, Stöckle M, Jocham D, Böhle A and Brandau S: Neutrophil
granulocytes are required for effective bacillus Calmette-Guérin
immunotherapy of bladder cancer and orchestrate local immune
responses. Cancer Res. 66:8250–8257. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
13
|
De Boer EC, De Jong WH, Steerenberg PA,
Aarden LA, Tetteroo E, De Groot ER, Van der Meijden AP, Vegt PD,
Debruyne FM and Ruitenberg EJ: Induction of urinary interleukin-1
(IL-1), IL-2, IL-6 and tumour necrosis factor during intravesical
immunotherapy with bacillus Calmette-Guérin in superficial bladder
cancer. Cancer Immunol Immunother. 34:306–312. 1992. View Article : Google Scholar : PubMed/NCBI
|
|
14
|
de Boer EC, Somogyi L, de Ruiter GJ, de
Reijke TM, Kurth KH and Schamhart DH: Role of interleukin-8 in
onset of the immune response in intravesical BCG therapy for
superficial bladder cancer. Urol Res. 25:31–34. 1997. View Article : Google Scholar : PubMed/NCBI
|
|
15
|
Monzavi-Karbassi B, Pashov A, Jousheghany
F, Artaud C and Kieber-Emmons T: Evaluating strategies to enhance
the anti-tumor immune response to a carbohydrate mimetic peptide
vaccine. Int J Mol Med. 17:1045–1052. 2006.PubMed/NCBI
|
|
16
|
Yoshie O, Aso H, Nanjo M, Tamura K, Ebina
T and Ishida N: Antitumor effect of recombinant human interferon
alpha A/D on Meth-A sarcoma in mice. Jpn J Cancer Res. 77:413–418.
1986.PubMed/NCBI
|
|
17
|
Huntington ND, Vosshenrich CA and Di Santo
JP: Developmental pathways that generate natural-killer-cell
diversity in mice and humans. Nat Rev Immunol. 7:703–714. 2007.
View Article : Google Scholar : PubMed/NCBI
|
|
18
|
Kim JM, Kim JS, Jung HC, Song IS and Kim
CY: Apoptosis of human gastric epithelial cells via caspase-3
activation in response to Helicobacter pylori infection: Possible
involvement of neutrophils through tumor necrosis factor alpha and
soluble Fas ligands. Scand J Gastroenterol. 35:40–48. 2000.
View Article : Google Scholar : PubMed/NCBI
|
|
19
|
Bisiaux A, Boussier J, Duffy D,
Quintana-Murci L, Fontes M and Albert ML; Milieu Intérieur
Consortium, : Deconvolution of the response to bacillus
Calmette-Guérin reveals NF-κB-induced cytokines as autocrine
mediators of innate immunity. Front Immunol. 8:7962017. View Article : Google Scholar : PubMed/NCBI
|
|
20
|
Queiroz DM, Guerra JB, Rocha GA, Rocha AM,
Santos A, De Oliveira AG, Cabral MM, Nogueira AM and De Oliveira
CA: IL1B and IL1RN polymorphic genes and Helicobacter pylori cagA
strains decrease the risk of reflux esophagitis. Gastroenterology.
127:73–79. 2004. View Article : Google Scholar : PubMed/NCBI
|
|
21
|
Kayagaki N, Yamaguchi N, Nakayama M,
Kawasaki A, Akiba H, Okumura K and Yagita H: Involvement of
TNF-related apoptosis-inducing ligand in human CD4+ T cell-mediated
cytotoxicity. J Immunol. 162:2639–2647. 1999.PubMed/NCBI
|
|
22
|
Kayagaki N, Yamaguchi N, Nakayama M, Eto
H, Okumura K and Yagita H: Type I interferons (IFNs) regulate tumor
necrosis factor-related apoptosis-inducing ligand (TRAIL)
expression on human t cells: A novel mechanism for the antitumor
effects of type I IFNs. J Exp Med. 189:1451–1460. 1999. View Article : Google Scholar : PubMed/NCBI
|
|
23
|
Mariani SM and Krammer PH: Surface
expression of TRAIL/Apo-2 ligand in activated mouse T and B cells.
Eur J Immunol. 28:1492–1498. 1998. View Article : Google Scholar : PubMed/NCBI
|
|
24
|
Kashii Y, Giorda R, Herberman RB,
Whiteside TL and Vujanovic NL: Constitutive expression and role of
the TNF family ligands in apoptotic killing of tumor cells by human
NK cells. J Immunol. 163:5358–5366. 1999.PubMed/NCBI
|
|
25
|
Fanger NA, Maliszewski CR, Schooley K and
Griffith TS: Human dendritic cells mediate cellular apoptosis via
tumor necrosis factor-related apoptosis-inducing ligand (TRAIL). J
Exp Med. 190:1155–1164. 1999. View Article : Google Scholar : PubMed/NCBI
|
|
26
|
Griffith TS, Wiley SR, Kubin MZ, Sedger
LM, Maliszewski CR and Fanger NA: Monocyte-mediated tumoricidal
activity via the tumor necrosis factor-related cytokine, TRAIL. J
Exp Med. 189:1343–1354. 1999. View Article : Google Scholar : PubMed/NCBI
|
|
27
|
Renshaw SA, Parmar JS, Singleton V, Rowe
SJ, Dockrell DH, Dower SK, Bingle CD, Chilvers ER and Whyte MK:
Acceleration of human neutrophil apoptosis by TRAIL. J Immunol.
170:1027–1033. 2003. View Article : Google Scholar : PubMed/NCBI
|
|
28
|
Ludwig AT, Moore JM, Luo Y, Chen X,
Saltsgaver NA, O'Donnell MA and Griffith TS: Tumor necrosis
factor-related apoptosis-inducing ligand: A novel mechanism for
Bacillus Calmette-Guerin-induced antitumor activity. Cancer Res.
64:3386–3390. 2004. View Article : Google Scholar : PubMed/NCBI
|
|
29
|
Morales A, Eidinger D and Bruce AW:
Intracavitary bacillus Calmette-Guerin in the treatment of
superficial bladder tumors. J Urol. 116:180–183. 1976. View Article : Google Scholar : PubMed/NCBI
|
|
30
|
Kandoth C, McLellan MD, Vandin F, Ye K,
Niu B, Lu C, Xie M, Zhang Q, McMichael JF, Wyczalkowski MA, et al:
Mutational landscape and significance across 12 major cancer types.
Nature. 502:333–339. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
31
|
Kusumanto YH, Dam WA, Hospers GA, Meijer C
and Mulder NH: Platelets and granulocytes, in particular the
neutrophils, form important compartments for circulating vascular
endothelial growth factor. Angiogenesis. 6:283–287. 2003.
View Article : Google Scholar : PubMed/NCBI
|
